Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2023) 90 EP675 | DOI: 10.1530/endoabs.90.EP675

ECE2023 Eposter Presentations Pituitary and Neuroendocrinology (234 abstracts)

Metabolic and surgical outcomes of adult patients with craniopharyngiomapatients undergoing extended transsphenoidal surgery (ETS) at a referral center

Ana Piñar Gutiérrez 1 , Elena Dios 1 , Eva Venegas-Moreno 1 , Pablo Remon 1 , Bothayna Oulad Ahmed 1 , Ariel Kaen 1 , Eugenio Cárdenas 1 , Elena Fajardo 1 , David Cano Gonzales 1 & Alfonso Soto-Moreno 1


Virgen del Rocío University Hospital, Sevilla, Spain


Objectives: To describe the metabolic and surgical outcomes of adult patients with craniopharyngioma undergoing extended transsphenoidal surgery (ETS). Secondary: to compare surgical outcomes with patients undergoing conventional transcranial surgery (CTS).

Methods: Retrospective observational study. Adult patients with craniopharyngiomas undergoing ETS between 2015 and 2020 were included. Descriptive analysis was performed by obtaining median and quartiles for quantitative variables and frequency for qualitative variables. For the comparison between groups, a matched cohort of patients with craniopharyngioma who underwent CTS was used and a Fisher test was performed for qualitative variables.

Results: n=16. Male=7(43.8%); age=52.5(37.7–66) years. Follow-up time=44.5(30–63) months. BMI pre-surgery=26.01(22.72–28.51)kg/m2. The BMI increase at first year after surgery was 18.14%(7.2–24.26%). Obesity was present in 56.5% at first year post-surgery, although 77.7% were grade I (WHO classification). During follow-up, 25% developed type 2 diabetes and dyslipidaemia.

Table 1 Post-surgical complications at one month and one year post-ETS.
First month post-ETS (n=16)First year post-ETS (n=14)
Complications after surgery15(93.8%)13(92.8%)
Diabetes insipidus15(93.8%)12(85.7%)
Adipsia 0(0%)1(7.1%)
Panhypopituitarism14(87.5%)11(78.5%)
Hypothyroidism15(93.8%)13(92.8%)
Adrenal insufficiency17(87.5%)12(85.7%)
Hydrocephalus11(32.4%)1(7.1%)
Seizures/anti-epileptic treatment1(6.3%)1(7.1%)
Cerebrospinal fluid fistula1(6.3%)0(0%)
Central nervous system infection3(18.8%)0(0%)
Visual disturbances9(56.3%)7(50%)
Psychiatric disorders1(6.3%)1(7.1%)
Neurological disorders 3(18.8%)4(28.5%)
Table 2 Surgical complications in which significant or near-significant differences were obtained between patients undergoing ETS vs CTS.
ETSCTSP
At first monthAdipsia0(0%)7(20.6%)0.05
Seizures1(6.3%)11(32.4%)0.03
Psychiatric disorders1(6.3%)12(35.3%)0.021
Neurological disorders 3(18.8%)7(50%)0.023
At first yearAnti-epileptic treatment1(7.1%)11(39.2%)0.03
Psychiatric disorders1(7.1%)12(42.8%)0.018
Hydrocephalus1(7.1%)9(32.1%)0.075

Conclusions The most frequent metabolic complication after ETS in patients presenting with craniopharyngioma was obesity, present in 56% of patients in our study. Surgical complications were very frequent (93.8% and 92.8% one month and one year after surgery) due to the high rate of diabetes insipidus (98.8% and 85.7%) and hypopituitarism (87.5% and 78.5%). These data are consistent with the scientific literature and lower than with CTS. ETS compared to CTS reduces adipsia, seizures and psychiatric and surgical complications at first month and hydrocephalus, need for antiepileptic treatment and psychiatric complications at first year after surgery.

Volume 90

25th European Congress of Endocrinology

Istanbul, Turkey
13 May 2023 - 16 May 2023

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.